Highlighted Stocks: Comcast Corporation (NASDAQ:CMCSA), Amtech Systems (NASDAQ:ASYS), pSivida Corp. (NASDAQ:PSDV)

Applied Materials, Inc. (NASDAQ:AMAT) shares moved up 1.27% in last trading session and ended the day at $18.75. AMAT Gross Margin is 40.90% and its has a return on assets of 10.00%. Applied Materials, Inc. (NASDAQ:AMAT) quarterly performance is 29.10%.

On 18 December, Applied Materials, Inc. (NASDAQ:AMAT) announced the appointment of Adrianna Ma to serve on its Board of Directors, effective immediately. Ms. Ma has also been appointed to serve as a member of the Audit Committee of the Board.

Applied Genetic Technologies Corporation (NASDAQ:AGTC) ended the last trading day at $19.48. Company weekly volatility is calculated as 6.30% and price to cash ratio as 2.11. Applied Genetic Technologies Corporation (NASDAQ:AGTC) showed a weekly performance of 13.39%.

Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, announced that the company has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ:NBI), effective December 21, 2015.

On 22 December, Comcast Corporation (NASDAQ:CMCSA) shares moved up 0.76% and was closed at $56.89. CMCSA EPS growth in last 5 year was 20.50%. Comcast Corporation (NASDAQ:CMCSA) year to date (YTD) performance is -0.27%.

Comcast Corporation (NASDAQ:CMCSA) will host a conference call with the financial community to discuss financial results for the fourth quarter and full year 2015 on Wednesday, February 3, 2016 at 8:30 a.m. Eastern Time (ET). Comcast will issue a press release reporting its results earlier that morning.

Amtech Systems Inc. (NASDAQ:ASYS) shares moved down -22.74% in last trading session and ended the day at $6.42. ASYS Gross Margin is 25.70% and its has a return on assets of -6.20%. Amtech Systems Inc. (NASDAQ:ASYS) quarterly performance is 38.06%.

On 9 December, Amtech Systems, Inc. (NASDAQ:ASYS), announced that its Board of Directors has authorized a new stock repurchase program of up to $4 million of the company’s outstanding common stock, par value $0.01 per share. This new program will commence immediately and is expected to be completed over the next 12 months. As of December 3, 2015, Amtech had approximately 13.2 million shares of common stock outstanding.

pSivida Corp. (NASDAQ:PSDV) caters to the Healthcare space. Its weekly performance is 27.92%. On the last day of trading company shares ended up at $4.49. pSivida Corp. (NASDAQ:PSDV) distance from 50-day simple moving average (SMA50) is -8.91%.

pSivida Corp. (NASDAQ:PSDV) announced positive topline results from its first Phase 3 clinical trial evaluating the safety and efficacy of Medidur™ for the treatment of chronic noninfectious uveitis affecting the posterior of the eye (posterior uveitis). The 129 patient, multi-center, randomized and double-blinded trial was highly statistically significant in meeting its primary efficacy endpoint of prevention of recurrence of disease at six months (p less than 0.00000001; intent to treat analysis).